Abstract Submission

The Scientific Conference Committee reviews each abstract that will be accepted. The scientific quality of the abstracts presented contributes substantially to making the AHR Symposium 2020 a leading international forum for new toxicology to therapeutics research.

After registering for the AHR Symposium, you will receive a confirmation email which includes an abstract submission registration link.

The deadline for abstract submission has been extended to April 1, 2020 and presenters will be notified in mid-April 2020 of their abstract/poster acceptance.  

Please follow the standards below for abstract acceptance. The following guidelines apply to each abstract:

  • 2,300 total characters – including title, body, author last name and institution(s)
    Spaces not included in character count.
  • NO Tables, Figures, Chemical Structures or Attachments
  • Times New Roman – 12 pt font MUST be used, no exceptions
  • Justified 1” margins must be used
  • Document must be saved as a Word doc or docx file
  • All Presenters must register and pay to attend the symposium
  • All non-standard acronyms must be defined


Abstracts describing the results of experimental studies MUST answer two (2) questions:

  • What was done?
  • What was found?
  • A statement of the rationale and scope of the study presented
  • A brief description of the experimental procedures
  • The data that resulted from the study
  • The principal conclusion(s) based on interpretation of the results


Authors should also consider the following when developing the abstract:

  • Test compounds utilized in the study should be identified in the abstract.In cases where the length of the proper chemical name precludes its use, a manufacturer’s identification number, etc. may be acceptable provided the structure and chemical identity of the compound are included in the presentation. Abstracts will NOT be accepted if the authors are unable to disclose chemical identity of the compound used in the study
  • When describing your research or assessment approaches, please refrain from using introductory phrases such as “will be presented”. Phrases such as “results/data will be discussed” convey no information as to the outcome of the studies and are unacceptable
  • To help describe results of “big data” studies and stay within the 2,300 word character abstract, include specific examples of findings to help meet the requirement for description of data
  • All animal experimentation must be carried out in accordance with the (IACUC) An Institutional Animal Care and Use Committee approval
  • All abstracts submitted with human testing require that IRB protocol has been followed and approval obtained


Studies that do not describe laboratory or field experiments, such as reports on educational, ethics, legal or social initiatives, authors should:

  • Describe the research or assessment approach instead of experimental procedures
  • Summarize the study’s results or findings explicitly
  • Clearly articulate the implications for stakeholders


Abstracts describing new initiatives or science policy in the regulatory community must clearly describe the impact on the practice of toxicology and/or risk assessment. Care should be taken to clearly distinguish between statements based on documented facts vs opinions. Literature surveys or reviews and background materials are insufficient in and of themselves.

Instructions for Poster Session Presenters

  • Posters must be 36” x 46” in either landscape or portrait format
  • Headers come first – Top of each poster you should post a label stating the title, author(s) and author(s) affiliation in addition to the abstract final ID number
  • COI and Logos – Conflict of Interest disclosures should be included on your poster. Institutional logos, but no product logos are allowed on posters
  • Clarity and Readability – Make sure your poster is understandable without an oral presentation and readable from at least 3 feet away – remember your poster will be on display all day
  • Visual Balance – Make an initial layout, paying attention to the proportions of figures, tables and text. Maintain a balance of using ~50% of the poster board area for figures and tables
  • Include your objective, the design/methods, the results and conclusion – but avoid displaying a short manuscript – experimental details should be concise – tables and conclusions should be clearly stated
  • Don’t overload your poster with excessive text or date. Organize table and figures chronologically in progression
  • Velcro for affixing posters to boards will be provided at the registration table
  • Posters will be featured Monday, Tuesday, Wednesday and at breaks during the Symposium – more details will be provided at notification in April 2020

Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!